Results 171 to 180 of about 57,164 (280)
Missed Opportunities on Emergency Remdesivir Use [PDF]
, 2020 Ameet Sarpatwari +2 more
openalex +1 more source
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
, 2020 Muneerah M Aleissa +5 more
openalex +2 more sources
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis [PDF]
, 2020 Weichung Joe Shih, Chen Yao, Tai Xie
openalex +1 more source
Successful management of remdesivir extravasation [PDF]
Revista Española de Quimioterapia, 2022 Conde Estévez, David +3 more
openaire +3 more sources
Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic
, 2020 Sarah Lim +11 more
openalex +1 more source
IDCases, 2022 Remdesivir is a direct-acting inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase that is used to treat severe COVID-19 infections. We report a patient with severe COVID-19 pneumonia who experienced palpitations and syncope two days after starting ...
Shmeylan Al Harbi +6 more
doaj
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era. [PDF]
BACKGROUND: Patients with immunocompromising conditions are at increased risk for coronavirus disease 2019 (COVID-19)-related hospitalizations and deaths.
Amin, Alpesh +7 more
core +1 more source